Becton, Dickinson and Company BDX

183.82 4.59 2.56% as of 25 Sep
Market cap
$48.8B
P/E
55.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Becton, Dickinson and Company (BDX) P/B ratio

As of 25 September 2026, Becton, Dickinson and Company (BDX) trades at a P/B ratio of 2.1×. Over the past ten years it has ranged from 1.5× (May 2025) to 4.4× (March 2015); the current reading is higher than 21% of that period. That is below the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 1.7× (21.42%)
FY2024 2.1× (5.67%)
FY2023 2.2× 13.86%
FY2022 2.0× (14.27%)
FY2021 2.3× 9.96%
FY2020 2.1× (15.68%)
FY2019 2.5× (0.44%)
FY2018 2.5× (1.98%)
FY2017 2.5× (33.71%)
FY2016 3.8× 33.54%

Quarterly

Period P/B ratio Change
Jun 2026 1.7× (6.86%)
Mar 2026 1.8× 6.10%
Dec 2025 1.7× 3.38%
Sep 2025 1.7× 9.20%
42 more quarters

Against its own ten years

Low 1.5× High 4.4×
Ten-year median 2.3×
Current reading's percentile 21

P/B ratio against peers

Company P/B ratio
ALC Alcon compare 1.5×
MDLN Medline Inc. compare 1.6×
BAX Baxter International Inc. compare 2.0×
BDX Becton, Dickinson and Company 2.1×
SOLV Solventum Corporation compare 3.2×
RMD ResMed Inc. compare 4.9×
RGEN Repligen Corporation compare 5.1×
ISRG Intuitive Surgical, Inc. compare 7.8×
WST West Pharmaceutical Services, Inc. compare 8.8×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on BDX